Global Markets Direct Research

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

Reports
Global Markets Direct’s wide variety of reports offer a targeted solution for marketing and strategic planning. These reports include in-depth company reports such as Company Market Share reports, which give a detailed breakdown of revenues by market and region, and Company Asset Reports, which give details of companies’ key assets by geography.
Company Strategic Analysis Reports include in-depth value chain and SWOT analysis, while Company Financial Deal Profiles highlight key financial deals that have shaped the company. Global Markets Direct also produces a wide range of market reports giving access to high value unique databases of information, examples include historic and forecast asset reports and market share reports covering value, volume, distribution and company shares.

Sectors and Geographies Covered
Global Markets Direct specializes in the Energy and Medical Equipment Markets. It has a global scope, covering a broad range of countries constituting more than 90% of global revenues in each of the industries it covers.

Research Methodology
With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.
Global Markets Direct Research
 

List of reports from Global Markets Direct Research

1  2    4    6  7  8  9  10  
Sinusitis - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Sinusitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Pemphigus - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Pemphigus, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Acid Sphingomyelinase Deficiency (Niemann-Pick Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Dysmenorrhea - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Dysmenorrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Nerve Injury - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... therapeutic development for Nerve Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Becker Muscular Dystrophy - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... information on the therapeutic development for Becker Muscular Dystrophy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Muscle Spasm - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... therapeutic development for Muscle Spasm, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Pheochromocytoma - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Pheochromocytoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Venous (Vein) Thrombosis - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... information on the therapeutic development for Venous (Vein) Thrombosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Pneumocystis Infection - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... therapeutic development for Pneumocystis Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Ureter Cancer - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... therapeutic development for Ureter Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Sjogren's Syndrome - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... therapeutic development for Sjogren's Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Cryptosporidiosis - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Cryptosporidiosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Invaginata, Bamboo Hair)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of ...  |  read more...
USD 2,000
Osteopenia - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Osteopenia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Osteonecrosis - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Osteonecrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Salivary Gland Cancer - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... information on the therapeutic development for Salivary Gland Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Hypoxia - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Hypoxia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Muscle Spasticity - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... therapeutic development for Muscle Spasticity, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Tardive Dyskinesia - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... therapeutic development for Tardive Dyskinesia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... overview of the Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome), complete with ...  |  read more...
USD 2,000
Phenylketonuria (PKU) - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... therapeutic development for Phenylketonuria (PKU), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Renal Insufficiency - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... therapeutic development for Renal Insufficiency, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Ageing - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Ageing, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Community Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Community Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections, complete with comparative analysis at various stages, therapeutics assessment by ...  |  read more...
USD 2,000
1  2    4    6  7  8  9  10  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!